Newsroom

Press Release

NeoGenomics Announces New Directors

NeoGenomics Set to Join Russell 3000 Index

NeoGenomics Reports 27% Revenue Growth Driven by Strong Volume Gains and PathLogic Acquisition

NeoGenomics Announces Promotions

NeoGenomics Schedules its Q1 2015 Earnings Release for April 28, 2015

NeoGenomics Reports Record Revenue of $25.0 Million, Adjusted EBITDA of $2.8 MM and Net Income of $0.02 per Share for the Fourth Quarter 2014

NeoGenomics Schedules its Q4 2014 and Full Year 2014 Earnings Release for February 24, 2015

NeoGenomics Raises Revenue Guidance to $25 Million and EPS Guidance to $0.01 - $0.02 per share for Quarter 4, 2014

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients